Repurposing of neprilysin inhibitor 'sacubitrilat'as an anti-cancer drug by modulating epigenetic and apoptotic regulators
N Kumbhar, S Nimal, D Patil, VF Kaiser, J Haupt… - Scientific Reports, 2023 - nature.com
Modifications in the epigenetic landscape have been considered a hallmark of cancer.
Histone deacetylation is one of the crucial epigenetic modulations associated with the …
Histone deacetylation is one of the crucial epigenetic modulations associated with the …
[HTML][HTML] Atovaquone exerts its anticancer effect by inhibiting Na+/K+-ATPase ion transport in canine cancer cells
Y Alharbi - Veterinary World, 2023 - ncbi.nlm.nih.gov
Materials and Methods: Canine cell lines were treated with various concentrations (2.5, 5,
10, 15, and 20 μM) of atovaquone for 24, 48, and 72 h. Human cell lines were used as a …
10, 15, and 20 μM) of atovaquone for 24, 48, and 72 h. Human cell lines were used as a …
Pharmaceutical drug metformin and MCL1 inhibitor S63845 exhibit anticancer activity in myeloid leukemia cells via redox remodeling
G Valiulienė, A Vitkevičienė, G Skliutė, V Borutinskaitė… - Molecules, 2021 - mdpi.com
Metabolic landscape and sensitivity to apoptosis induction play a crucial role in acute
myeloid leukemia (AML) resistance. Therefore, we investigated the effect of metformin, a …
myeloid leukemia (AML) resistance. Therefore, we investigated the effect of metformin, a …
Drug repurposing: databases and pipelines
AV Kowshik, M Manoj, S Sowmyanarayan… - CNS spectrums, 2024 - cambridge.org
The concept of drug repurposing is focused on the repositioning of drug molecules that have
already undergone safety trials. There are different strategies for drug repurposing. Network …
already undergone safety trials. There are different strategies for drug repurposing. Network …
Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and …
F Arjmand, S Tabassum - Dalton Transactions, 2024 - pubs.rsc.org
Bilastine (BLA), 2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo [d] imidazole-2-yl)-piperidin-1-yl)-
ethyl)-phenyl)-2-methylpropanoic acid, is an active antihistamine drug. With the idea of …
ethyl)-phenyl)-2-methylpropanoic acid, is an active antihistamine drug. With the idea of …
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease
C Anderson, M Bucholc, PL McClean, SD Zhang - Biomolecules, 2023 - mdpi.com
Alzheimer's disease (AD) is a complex neurodegenerative condition that is characterized by
the build-up of amyloid-beta plaques and neurofibrillary tangles. While multiple theories …
the build-up of amyloid-beta plaques and neurofibrillary tangles. While multiple theories …
[PDF][PDF] Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
Cancer represents a significant global health and economic burden due to its high mortality
rates. While effective in some instances, traditional chemotherapy often falls short of entirely …
rates. While effective in some instances, traditional chemotherapy often falls short of entirely …
Repurposing simvastatin in cancer treatment: an updated review on pharmacological and nanotechnological aspects
N Ara, A Hafeez, SP Kushwaha - Naunyn-Schmiedeberg's Archives of …, 2024 - Springer
Management of cancer is challenging due to non-targeting and high side effect issues. Drug
repurposing is an innovative method for employing medications for other disease therapy in …
repurposing is an innovative method for employing medications for other disease therapy in …
Anticancer Activity of Anti-Tubercular Compound (s) Designed on Pyrrolyl Benzohydrazine Scaffolds: A Repurposing Study
The present study explored anti-tubercular pyrrole derivatives against cancer targets using
different in silico and in vitro approaches. Initially, nineteen anti-tubercular pyrrolyl …
different in silico and in vitro approaches. Initially, nineteen anti-tubercular pyrrolyl …
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma
B Hu, H Tan, L Yu, Q Liao… - Human & Experimental …, 2022 - journals.sagepub.com
Background Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …